| Douglas J Krasniewski, MPT | |
|
6590 S Rainbow Blvd Ste 230, Las Vegas, NV 89118-3322 | |
| (725) 726-7847 | |
| (725) 726-7876 |
| Full Name | Douglas J Krasniewski |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 22 Years |
| Location | 6590 S Rainbow Blvd Ste 230, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013954312 | NPI | - | NPPES |
| 1013954312 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1708 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Smith Therapy Partners | 1052731072 | 33 |
News Archive
A new study of the ribosome, the cell's protein-building machinery, sheds light on the oldest branches of the evolutionary tree of life and suggests that differences in ribosomal structure between the three main branches of that tree are "molecular fossils" of the early evolution of protein synthesis.
Scientists at Christiana Care Health System's Gene Editing Institute have developed a potentially breakthrough CRISPR gene-editing tool. It could allow researchers to take fragments of DNA extracted from human cells, put them into a test tube, and quickly and precisely engineer multiple changes to the genetic code, according to a new study published today in the CRISPR Journal.
New research by the Gladstone Institutes of Cardiovascular Disease (GICD) and the University of California, San Francisco (UCSF), has revealed the genetic determinants of fat storage in cells, which may lead to a new understanding of and potential treatments for obesity, diabetes, and heart disease. While scientists have long understood that lipid droplets contribute to fat build up in cells, the genes involved in droplet biology have been a focus of extensive research.
Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody oncology therapeutics using Zymeworks' proprietary Azymetric platform. Bi-specific antibodies have the potential to provide improved outcomes for patients by simultaneously targeting two tumor associated antigens to induce a synergistic therapeutic response.
A new study has found that heart failure patients with pre-existing type 2 diabetes have higher hospitalization and death rates, but that keeping blood sugars balanced can help lower the risk almost to that of heart failure patients without diabetes.
› Verified 7 days ago
| Provider Name | New Century Rehabilitation Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396777892 PECOS PAC ID: 3274422647 Enrollment ID: O20040312001184 |
News Archive
A new study of the ribosome, the cell's protein-building machinery, sheds light on the oldest branches of the evolutionary tree of life and suggests that differences in ribosomal structure between the three main branches of that tree are "molecular fossils" of the early evolution of protein synthesis.
Scientists at Christiana Care Health System's Gene Editing Institute have developed a potentially breakthrough CRISPR gene-editing tool. It could allow researchers to take fragments of DNA extracted from human cells, put them into a test tube, and quickly and precisely engineer multiple changes to the genetic code, according to a new study published today in the CRISPR Journal.
New research by the Gladstone Institutes of Cardiovascular Disease (GICD) and the University of California, San Francisco (UCSF), has revealed the genetic determinants of fat storage in cells, which may lead to a new understanding of and potential treatments for obesity, diabetes, and heart disease. While scientists have long understood that lipid droplets contribute to fat build up in cells, the genes involved in droplet biology have been a focus of extensive research.
Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody oncology therapeutics using Zymeworks' proprietary Azymetric platform. Bi-specific antibodies have the potential to provide improved outcomes for patients by simultaneously targeting two tumor associated antigens to induce a synergistic therapeutic response.
A new study has found that heart failure patients with pre-existing type 2 diabetes have higher hospitalization and death rates, but that keeping blood sugars balanced can help lower the risk almost to that of heart failure patients without diabetes.
› Verified 7 days ago
| Provider Name | Smith Therapy Partners |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1134758709 PECOS PAC ID: 1052731072 Enrollment ID: O20201013002673 |
News Archive
A new study of the ribosome, the cell's protein-building machinery, sheds light on the oldest branches of the evolutionary tree of life and suggests that differences in ribosomal structure between the three main branches of that tree are "molecular fossils" of the early evolution of protein synthesis.
Scientists at Christiana Care Health System's Gene Editing Institute have developed a potentially breakthrough CRISPR gene-editing tool. It could allow researchers to take fragments of DNA extracted from human cells, put them into a test tube, and quickly and precisely engineer multiple changes to the genetic code, according to a new study published today in the CRISPR Journal.
New research by the Gladstone Institutes of Cardiovascular Disease (GICD) and the University of California, San Francisco (UCSF), has revealed the genetic determinants of fat storage in cells, which may lead to a new understanding of and potential treatments for obesity, diabetes, and heart disease. While scientists have long understood that lipid droplets contribute to fat build up in cells, the genes involved in droplet biology have been a focus of extensive research.
Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody oncology therapeutics using Zymeworks' proprietary Azymetric platform. Bi-specific antibodies have the potential to provide improved outcomes for patients by simultaneously targeting two tumor associated antigens to induce a synergistic therapeutic response.
A new study has found that heart failure patients with pre-existing type 2 diabetes have higher hospitalization and death rates, but that keeping blood sugars balanced can help lower the risk almost to that of heart failure patients without diabetes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas J Krasniewski, MPT 10785 W Twain Ave Ste 250, Las Vegas, NV 89135-3026 Ph: (725) 726-7847 | Douglas J Krasniewski, MPT 6590 S Rainbow Blvd Ste 230, Las Vegas, NV 89118-3322 Ph: (725) 726-7847 |
News Archive
A new study of the ribosome, the cell's protein-building machinery, sheds light on the oldest branches of the evolutionary tree of life and suggests that differences in ribosomal structure between the three main branches of that tree are "molecular fossils" of the early evolution of protein synthesis.
Scientists at Christiana Care Health System's Gene Editing Institute have developed a potentially breakthrough CRISPR gene-editing tool. It could allow researchers to take fragments of DNA extracted from human cells, put them into a test tube, and quickly and precisely engineer multiple changes to the genetic code, according to a new study published today in the CRISPR Journal.
New research by the Gladstone Institutes of Cardiovascular Disease (GICD) and the University of California, San Francisco (UCSF), has revealed the genetic determinants of fat storage in cells, which may lead to a new understanding of and potential treatments for obesity, diabetes, and heart disease. While scientists have long understood that lipid droplets contribute to fat build up in cells, the genes involved in droplet biology have been a focus of extensive research.
Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody oncology therapeutics using Zymeworks' proprietary Azymetric platform. Bi-specific antibodies have the potential to provide improved outcomes for patients by simultaneously targeting two tumor associated antigens to induce a synergistic therapeutic response.
A new study has found that heart failure patients with pre-existing type 2 diabetes have higher hospitalization and death rates, but that keeping blood sugars balanced can help lower the risk almost to that of heart failure patients without diabetes.
› Verified 7 days ago
Athleticare Physical Therapist Medicare: Medicare Enrolled Practice Location: 8333 S Eastern Ave, Las Vegas, NV 89123 Phone: 702-263-3802 Fax: 702-270-7740 | |
Ceferino Villafuerte, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2029 Winter Wind St, Las Vegas, NV 89134 Phone: 702-869-6714 | |
Kelsey Zane Daniels, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6345 S Jones Blvd Ste 300, Las Vegas, NV 89118 Phone: 702-515-4009 | |
Dr. Erin Longhurst, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2650 N Tenaya Way, Suite 180, Las Vegas, NV 89128 Phone: 702-240-2952 | |
Mr. Gladstone George, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2832 S Maryland Pkwy, Las Vegas, NV 89109 Phone: 702-735-5848 Fax: 702-735-6218 | |
Ati Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6830 W Oquendo Rd, Suite 101, Las Vegas, NV 89118 Phone: 702-258-3066 | |
Chanha Hwang, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8174 Las Vegas Blvd S Ste 109-150, Las Vegas, NV 89123 Phone: 702-883-9528 Fax: 702-852-5715 |